telmisartan, Micardis (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

PREGNANCY: Medications that interfere with the angiotensin converting enzyme system, such as telmisartan, have been found to cause fetal and neonatal toxicity and death when taken by pregnant women. Pregnant mothers should discontinue use of telmisartan as soon as they know they are pregnant.

NURSING MOTHERS: It is not known if telmisartan is secreted into breast milk. Since most medicines are secreted into breast milk, potential risks and benefits need to be assessed in women who are nursing to determine if breast feeding or telmisartan should be discontinued.

SIDE EFFECTS: Like other angiotensin receptor blockers, telmisartan generally is well-tolerated. The most common side effects are headache, dizziness, back pain, fatigue, stomach upset, upper respiratory tract infections, hyperkalemia, and diarrhea. Patients also may experience impotence, reduced renal function, and allergic reactions. Rhabdomyolysis (inflammation and destruction of muscle) and angioedema (swelling of soft tissues including those of the throat and larynx) are rare but serious side effects of telmisartan.

FDA Prescribing Information


Last Editorial Review: 4/17/2012



Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index